Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Psoriasis
Trial Locations (1)

94010

Hôpital Henri Mondor, Créteil

All Listed Sponsors
collaborator

Société de Dermatologie Française

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04841187 - Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis | Biotech Hunter | Biotech Hunter